• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Evidation Health and HHS to Develop Predictive Algorithm for COVID-19 Detection

Share:

June 8, 2020

Evidation Health today announced a new effort to develop an early warning algorithm to detect symptoms of COVID-19 and to understand susceptibility to infection, funded by the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services (HHS) and the Bill & Melinda Gates Foundation. Accelerating detection and containment of the virus is a crucial focus area for the Gates Foundation, which has committed $250 million to address the COVID-19 pandemic.

Early Warning System for COVID-19

The Evidation platform will analyze behavior, including sleep and activity patterns, alongside self-reported symptoms for 300 people at high risk of developing COVID-19. This builds on Evidation’s current, ongoing 150,000-person nationwide initiative tracking people’s health and attitudes during the pandemic, COVID-19 Pulse.

The analysis, performed in collaboration with non-profit 4YouandMe, will use de-identified data generated by self-reporting and wearable devices to track symptoms of COVID-19 in those at particularly high risk, including health care workers and other first responders, in order to better understand susceptibility to SARS-CoV-2 infection. One potential outcome of this work is an early warning algorithm to help individuals better understand and monitor their respiratory disease symptoms and take precautions against their spread.

“The ability to self-monitor and be informed of health status will empower Americans in their decisions to help slow the spread of this pandemic and improve health outcomes for people with COVID-19,” said BARDA Acting Director, Gary Disbrow, Ph.D. “This pilot study is not only an early step in demonstrating the utility of models developed using person-generated health data but also may provide data to better understand the varied symptoms of COVID-19.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • PathAI, Cleveland Clinic Partner to Use AI-Enabled Pathology for ResearchPathAI, Cleveland Clinic Partner to Use AI-Enabled Pathology for Research
  • Crescent European Specialty Lending Announces Financing for AIO II, Holding Company of The Netherlands-Based Pharmacy Chain Medsen and Compounding Pharmacy CebanCrescent European Specialty Lending Announces Financing for AIO II, Holding Company of The Netherlands-Based Pharmacy Chain Medsen and Compounding Pharmacy Ceban
  • The Crucial Role of SDOH Data in Value-Based CareThe Crucial Role of SDOH Data in Value-Based Care
  • ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.ADVANZ PHARMA Corp. Limited to Acquire Specialty Pharmaceutical Company Correvio Pharma Corp.
  • Siemens Acquires Brightly for $1.57B to Enhance Built InfrastructureSiemens Acquires Brightly for $1.57B to Enhance Built Infrastructure
  • Keck Medicine of USC Deploys Virtual Check-Ins to Reduce Risk of COVID-19 ExposureKeck Medicine of USC Deploys Virtual Check-Ins to Reduce Risk of COVID-19 Exposure
  • NLP is Raising the Bar on Accurate Detection of Adverse Drug EventsNLP is Raising the Bar on Accurate Detection of Adverse Drug Events
  • Italian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health’s Italian Subsidiary Napo EU S.p.A. for ClosingItalian Government Clears Merger Plan of Dragon SPAC S.p.A. and Jaguar Health’s Italian Subsidiary Napo EU S.p.A. for Closing

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications